Endothelin receptor antagonists: a new therapeutic option for improving the outcome after solid organ transplantation?
Initially described as the most potent vasoconstrictor peptide, endothelin (ET) has also been shown to possess extraordinary immunomodulatory and proinflammatory properties. Because of this broad spectrum of biological activities, a possible role of the ET-system in solid organ transplantation has s...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2003
|
| In: |
Current vascular pharmacology
Year: 2003, Jahrgang: 1, Heft: 3, Pages: 281-299 |
| ISSN: | 1875-6212 |
| DOI: | 10.2174/1570161033476655 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2174/1570161033476655 Verlag, lizenzpflichtig, Volltext: https://www.eurekaselect.com/article/26048 
|
| Verfasserangaben: | Uwe Göttmann, Fokko J. van der Woude, Claude Braun |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1805503278 | ||
| 003 | DE-627 | ||
| 005 | 20230428181734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220601s2003 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1570161033476655 |2 doi | |
| 035 | |a (DE-627)1805503278 | ||
| 035 | |a (DE-599)KXP1805503278 | ||
| 035 | |a (OCoLC)1341460700 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Göttmann, Uwe |d 1974- |e VerfasserIn |0 (DE-588)124642071 |0 (DE-627)575608722 |0 (DE-576)294426175 |4 aut | |
| 245 | 1 | 0 | |a Endothelin receptor antagonists |b a new therapeutic option for improving the outcome after solid organ transplantation? |c Uwe Göttmann, Fokko J. van der Woude, Claude Braun |
| 264 | 1 | |c 2003 | |
| 300 | |a 19 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 01.06.2022 | ||
| 520 | |a Initially described as the most potent vasoconstrictor peptide, endothelin (ET) has also been shown to possess extraordinary immunomodulatory and proinflammatory properties. Because of this broad spectrum of biological activities, a possible role of the ET-system in solid organ transplantation has soon become a focus of research. Several studies demonstrated a pathogenetic involvement of ET in ischemia/reperfusion injury of heart, liver, kidney, and lung grafts. ET accumulates during cold storage of organs and can be detected in the effluent preservation solution. In addition ET is very, likely to play a pivotal role in the development of chronic rejection, which represents the major cause of late allograft loss. Increased expression of components of the ET-system has been described in areas of neointimal proliferation, a hallmark of chronic graft rejection. Both selective ET-A as well as non-selective ET-A/B receptor antagonists improved histomorphological and functional sequelae of chronic rejection. However these data have largely been derived from experimental animal transplantation, and ET receptor blockers have only recently been introduced in clinical medicine. A significant number of investigational drugs are now being tested in humans, with a main focus on cardiovascular diseases, such as congestive heart failure and pulmonary hypertension. First results have markedly dampened the initial enthusiastic vision of ET receptor blockers being organoprotective super-weapons. Thus the clinical potential of ET antagonists in general, and especially in solid-organ transplantation, is still to be defined. | ||
| 650 | 4 | |a Animals | |
| 650 | 4 | |a Endothelin Receptor Antagonists | |
| 650 | 4 | |a Endothelin-1 | |
| 650 | 4 | |a Endothelins | |
| 650 | 4 | |a Graft Rejection | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Organ Transplantation | |
| 650 | 4 | |a Randomized Controlled Trials as Topic | |
| 650 | 4 | |a Receptors, Endothelin | |
| 650 | 4 | |a Treatment Outcome | |
| 700 | 1 | |a Woude, Fokko J. van der |d 1953-2006 |e VerfasserIn |0 (DE-588)173440835 |0 (DE-627)698355067 |0 (DE-576)134286820 |4 aut | |
| 700 | 1 | |a Braun, Claude |e VerfasserIn |0 (DE-588)1076918220 |0 (DE-627)835463109 |0 (DE-576)445789050 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current vascular pharmacology |d Hilversum [u.a.] : Bentham Science Publ., 2003 |g 1(2003), 3, Seite 281-299 |h Online-Ressource |w (DE-627)367170671 |w (DE-600)2114940-9 |w (DE-576)273887432 |x 1875-6212 |7 nnas |a Endothelin receptor antagonists a new therapeutic option for improving the outcome after solid organ transplantation? |
| 773 | 1 | 8 | |g volume:1 |g year:2003 |g number:3 |g pages:281-299 |g extent:19 |a Endothelin receptor antagonists a new therapeutic option for improving the outcome after solid organ transplantation? |
| 856 | 4 | 0 | |u https://doi.org/10.2174/1570161033476655 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.eurekaselect.com/article/26048 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220601 | ||
| 993 | |a Article | ||
| 994 | |a 2003 | ||
| 998 | |g 1076918220 |a Braun, Claude |m 1076918220:Braun, Claude |d 60000 |d 61400 |e 60000PB1076918220 |e 61400PB1076918220 |k 0/60000/ |k 1/60000/61400/ |p 3 |y j | ||
| 998 | |g 173440835 |a Woude, Fokko J. van der |m 173440835:Woude, Fokko J. van der |d 60000 |d 61400 |e 60000PW173440835 |e 61400PW173440835 |k 0/60000/ |k 1/60000/61400/ |p 2 | ||
| 998 | |g 124642071 |a Göttmann, Uwe |m 124642071:Göttmann, Uwe |d 60000 |d 61400 |e 60000PG124642071 |e 61400PG124642071 |k 0/60000/ |k 1/60000/61400/ |p 1 |x j | ||
| 999 | |a KXP-PPN1805503278 |e 4142074571 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.2174/1570161033476655"],"eki":["1805503278"]},"origin":[{"dateIssuedDisp":"2003","dateIssuedKey":"2003"}],"name":{"displayForm":["Uwe Göttmann, Fokko J. van der Woude, Claude Braun"]},"relHost":[{"pubHistory":["1.2003 -"],"part":{"year":"2003","issue":"3","pages":"281-299","text":"1(2003), 3, Seite 281-299","volume":"1","extent":"19"},"note":["Gesehen am 14.01.16"],"disp":"Endothelin receptor antagonists a new therapeutic option for improving the outcome after solid organ transplantation?Current vascular pharmacology","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"367170671","title":[{"title_sort":"Current vascular pharmacology","title":"Current vascular pharmacology"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Hilversum [u.a.]","publisher":"Bentham Science Publ.","dateIssuedKey":"2003","dateIssuedDisp":"2003-"}],"id":{"issn":["1875-6212"],"eki":["367170671"],"zdb":["2114940-9"]}}],"physDesc":[{"extent":"19 S."}],"title":[{"title":"Endothelin receptor antagonists","subtitle":"a new therapeutic option for improving the outcome after solid organ transplantation?","title_sort":"Endothelin receptor antagonists"}],"person":[{"display":"Göttmann, Uwe","roleDisplay":"VerfasserIn","role":"aut","family":"Göttmann","given":"Uwe"},{"role":"aut","display":"Woude, Fokko J. van der","roleDisplay":"VerfasserIn","given":"Fokko J. van der","family":"Woude"},{"family":"Braun","given":"Claude","roleDisplay":"VerfasserIn","display":"Braun, Claude","role":"aut"}],"recId":"1805503278","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 01.06.2022"]} | ||
| SRT | |a GOETTMANNUENDOTHELIN2003 | ||